Official ESCRS | European Society of Cataract & Refractive Surgeons

 

Posters

Search Title by author or title

Early and long-term complications of secondary intraocular lens implantation with scleral fixation

Poster Details

First Author: B.Kemer Atik TURKEY

Co Author(s):    C. Altan   A. Agca                 

Abstract Details

Purpose:

The objective of the study was to investigate early and long term complications of secondary scleral fixated intraocular lens (IOL) implantation

Setting:

Beyoglu Eye Training and Research Hospital, University of Health Science, ISTANBUL, TURKEY

Methods:

Ninety-four eyes of 94 consecutive patients who underwent secondary scleral fixated IOL implantation were enrolled this study. Patients over 18 of age and with at least 12 months regular follow-up were included. Z suture scleral fixation technique was applied to all patients. The cause of aphakia, preoperative and postoperative uncorrected visual acuity, best corrected visual acuity, intraocular pressure and complications during the follow-up period were investigated retrospectively.

Results:

In early postoperative period, corneal edema was observed in 18 (19.1%) patients, IOP elevation in 19 (20.2%) patients and vitreous hemorrhage in 3 (3.3%) patients. Preoperative glaucoma was present in 6 (31.6%) patients with early IOP elevation. In the late postoperative period, cystoid macular edema (CME) in 9 (9.6%) patients, IOL capture in 5 (5.3%) patients, epiretinal membrane in 4(4.3%) patients, IOL dislocation in 2(2.1%) patients, permanent IOP elevation in 2(% 2.1) patients, hypotony in 1(1.1%) patient, permanent corneal edema in 1(1.1%) patient and pigment dispersion in 1(1.1%) patient were observed. Seven(7.4%) patients required surgical treatment due to postoperative complications.

Conclusions:

The most common early complications after secondary IOL implantation with scleral fixation are transient IOP elevation and corneal edema. In the late postoperative period, CME appears to be the most common complication. The surgeons should be aware of these complications.

Financial Disclosure:

None

Back to Poster listing